The assessment of absorption of periplocin in situ via intestinal perfusion of rats by HPLC

Biomedical Chromatography

Volumn 22, Issue 2, 2008, Pages 196-201

  Xie, Yue Sheng ^a,c   Ren, Xiao Liang ^b   Pan, Gui Xiang ^b   Gao, Xiu Mei ^b   Liu, Chang Xiao ^c  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH   (China)

Author keywords

Absorption; HPLC UV; Intestinal permeability; Periplocin

Indexed keywords

BINARY ALLOYS; RATE CONSTANTS;

CORTEXES; HPLC-UV; INTER-DAY VARIATIONS; INTESTINAL ABSORPTION; INTESTINAL PERMEABILITIES; PERIPLOCIN; RAT JEJUNUM; SINGLE PASS; TIME POINTS; WISTAR RAT;

RATS;

CARDIAC GLYCOSIDE; PERIPLOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ARTIFACT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG PENETRATION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE ABSORPTION; INTESTINE PERFUSION; JEJUNUM; MALE; NONHUMAN; RAT; STATISTICAL ANALYSIS;

RATTUS; RATTUS NORVEGICUS;

EID: 39349103223     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.914     Document Type: Article

References (24)

1. Amidon GL, Lennernas H, Shah VP and Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research 1995; 12: 413-420.
2. Berggren S, Hoogstraate J, Fagerholm U and Lennernas H. Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models. European Journal of Pharmaceutical Sciences 2004; 21: 553-560.
3. China Pharmacopoeia Committee (CHP). Pharmacopeia of the People's Republic of China, Part 1. Chemical Industry Press, Beijing, 2005: 181.
4. Chiou WL. The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats. Biopharmaceutical Drug Disposition 1995; 16: 71-75.
5. Crouthame W and Sarapu A. Animal Models for Oral Drug Delivery in Man. American Pharmaceutical Association: Washington, DC, 1983; 27-106.
6. Egawa K, Kurihara Y, Ito T, Matsumoto M and Nose K. Induction of p16INK4a transcription and of cellular senescence by aclacinomycin-derivatives and cardiac glycosides. Biological and Pharmaceutical Bulletin 2002; 25: 461-465.
7. Fagerholm U, Johansson M and Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharmaceutical Research 1996; 13: 1336-1342.
8. Hogerle ML and Winne D. Drug absorption by the rat jejunum perfused in situ. Dissociation from the pH-partition theory and role of microclimate-pH and unstirred layer. Naunyn-Schmiedeberg's Archives of Pharmacology 1983; 322: 249-255.
9. Itokawa H, Xu JP and Takeya K. Studies on chemical constituents of anti-tumor fraction from Periploca sepium. Chemical and Pharmaceutical Bulletin 1988; 36: 982-986.
10. Lennernas H. Human intestinal permeability. Journal of Pharmaceutical Sciences 1998; 87: 403-410.
11. Li YH, Gao XM, Zhang BL, Xu Q, Liu H and Pan GX. Effect of the Chinese medicine Xiangjiapi on cardiac function of isolated hearts. Journal of Liaoning College of Traditional Chinese Medicine 2005; 7: 396-397.
12. Nie SF, Pan WS, Yang XG, Liu HF and Liu ZD. Evaluation of gravimetry in the rat single-pass intestinal perfusion technique. Chinese Journal of New Drugs 2005; 14: 1176-1179.
13. Shiau YF, Fernandez P, Jackson MJ and McMonagle S. Mechanisms maintaining a low-pH microclimate in the intestine. The American Journal of Physiology 1985; 248: 608-617.
14. Sinko PJ, Hu P, Waclawski AP and Patel NR. Oral absorption of anti-AIDS nucleoside analogues. 1. Intestinal transport of didanosine in rat and rabbit preparations. Journal of Pharmaceutical Sciences 1995; 84: 959-965.
15. 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. American Association of Pharmaceutical Scientists 2001; 3: 1-5.
16. Sutton SC, Rinaldi MT, McCarthy JM and Vukovinsky KE. A statistical method for the determination of absorption rate constant estimated using the rat single pass intestinal perfusion model and multiple linear regression. Journal of Pharmaceutical Sciences 2002; 91: 1046-1053.
17. Svensson US, Sandstrom R, Carlborg O, Lennernas H and Ashton M. High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement. Drug Metabolism and Disposition 1999; 27: 227-232.
18. Umehara K, Sumii N, Satoh H, Miyase T, Kuroyanagi M and Ueno A. Studies on differentiation inducers. V. Steroid glycosides from periplocae radicis cortex. Chemical and Pharmaceutical Bulletin 1995; 43: 1565-1568.
19. Xu LQ, Lu HZ and Zhang YL. Clinical observation on 147 cases of CHF with BeiwujiapiMistura: Chinese Medicine and Materia Medica 1998; 19: 29-23.
20. Yang Q, Huang W, Jozwik C, Lin Y, Glasman M, Caohuy H, Srivastava M, Esposito D, Gillette W, Hartley J and Pollard HB. Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proceedings of the National Academy of Sciences of the United States of America 2005; 102: 9631-9636.
21. Zhang L, Zheng Y, Chow MS and Zuo Z. Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. International Journal of Pharmaceutics 2004; 287: 1-12.
22. Zhang J, Shan BE, Zhang C, Zhao RN, Li QL, Liu JH, Li QM and Li RQ. The effect on the differentiation and maturation of dendritic cells by lupane acetate of cortex periplocae. Chinese Journal of Cellular and Molecular Imunology 2006a; 22: 26-32.
23. Zhang J, Shan BE, Liu GS, Zhao XT and Chen SH. Anti-tumor activity of extract from Periploca sepium Bge. Carcinogenesis, Teratogenesis and Mutagenesis 2006b; 2: 108-111.
24. Zornoza T, Cano-Cebrian MJ, Nalda-Molina R, Guerri C, Granero L and Polache A. Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 2004; 22: 347-356.